Impact of Helicobacter pylori-linked metabolic syndrome on non-alcoholic fatty liver disease and its connected atrial fibrillation risk.
Jannis KountourasMichael DoulberisApostolis PapaefthymiouStergios A PolyzosPublished in: Liver international : official journal of the International Association for the Study of the Liver (2020)
Keyphrases
- helicobacter pylori
- metabolic syndrome
- atrial fibrillation
- helicobacter pylori infection
- left atrial
- oral anticoagulants
- catheter ablation
- heart failure
- insulin resistance
- uric acid
- left atrial appendage
- percutaneous coronary intervention
- direct oral anticoagulants
- type diabetes
- cardiovascular disease
- cardiovascular risk factors
- coronary artery disease
- venous thromboembolism
- left ventricular